GMAB
Genmab·NASDAQ
--
--(--)
--
--(--)
4.04 / 10
Netural
Analyst sentiment is bullish: a single Buy rating (100%) and a Truist upgrade to Strong‑Buy. Fund‑flow score is 8.09 (excellent), with positive inflows across all size categories except medium. Overall capital movement strongly supports the stock.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-27
InstitutionWolfe Research
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for GMAB?
- GMAB holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.04/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
